Alcohol Use and Non-Communicable Diseases, is there a Relationship?

Download Article

DOI: 10.21522/TIJPH.2013.08.02.Art030

Authors : Nelson Sabila

Abstract:

Background and aims: The relationship between alcohol use and non- communicable disease prevalence has puzzled researchers for many years. Alcohol use is widely practiced globally and is believed to be a major contributor to injuries, mortality and the burden of disease. This review updates knowledge on risk relations between dimensions of alcohol use and health outcomes such as; cardiovascular diseases, chronic obstructive pulmonary diseases, diabetes and cancers.

Methods: Systematic review of reviews and meta- analyses on chronic health outcomes attributable to alcohol use. For dimensions of exposure: volume of alcohol use, alcohol concentration and patterns of drinking, in particular heavy drinking occasions were studied. In total, 89 reviews and meta-analyses were searched in Google Scholar, PubMed, Medline but 28 reviews published from 2016 onwards were included in the study.

Results: Most partly imputable illness classes showed monotonic relationships with volume of alcohol use: additional alcohol consumed posed a higher risk of disease or death. Exceptions were ischemic diseases and polygenic disease, with curvilinear relationships, and with beneficial effects of light to moderate drinking in people without heavy irregular drinking occasions. Biological pathways counsel a control of significant drinking occasions on further diseases; but, the lack of medical epidemiological studies measuring this dimension of alcohol use precluded an in-depth analysis.

Conclusions: Research confirms alcohol use as both a risk factor for non-communicable diseases and at the same time protective when taken in moderation. However, further epidemiological studies should emphasize assessment of Health outcomes based on the quantity, frequency and concentration of the alcoholic drink.

References:

[1].   Akinwale, O. P., Adeneye, A. K., Oyefara, J. O., Adejoh, P. E., Musa, Z. A., Oyedeji, K. S., … Adeneye, A. A. (2017).

[2].   Behavioral Risk Factors for Non-Communicable Diseases in Three Most Populous Nigerian Urban Slums. Journal of Public Health in Developing Countries 3(1): 327-338. http://www.jphdc.org/ ISSN 2059-5409.

[3].   American Cancer Society. Cancer Facts & Figures 2018. Atlanta: American Cancer Society; 2018.

[4].   American Diabetes Association. Classification and diagnosis of diabetes. Sec.2.In Standards of Medical Care in Diabetes 2017. Diabetes Care 2017; 40 (Suppl. 1): S11–S24.

[5].   American Diabetes Association. 2. Classification and diagnosis of diabetes: Standards of Medical Care in Diabetesd2019. Diabetes Care 2019; 42 (Suppl. 1): S13–S28; https://doi.org/10.2337/dc19-S002.

[6].   Afshar, S. E., FitzGerald, J. M., Doyle-Waters, M. M., Sadatsafavi, M. (2016). The global economic. burden of asthma and chronic obstructive pulmonary disease. Int J Tuberc Lung Dis 20(1):11–23 Q 2016. The Union

http://dx.doi.org/10.5588/ijtld.15.0472.

[7].   Benjamin, E. J., Virani, S. S., Callaway, C. W., Chamberlain, A. M., Chang, A. R., Cheng, S.… Muntner, P. (2018). American Heart Association Council on Epidemiology and Prevention Statistics Committee and Stroke Statistics Subcommittee. Heart Disease and Stroke Statistics-2018 Update: A Report from the American Heart Association. Circulation. Mar 20; 137(12): e67-e492. Doi: 10.1161/CIR.0000000000000558. Epub 2018 Jan 31.

[8].   Bertoglia, M. P., Gormaz, J.G., Libuy, M., Sanhueza, D., Gajardo, A., Srur, A., Wallbaum, M., & Erazo, M. (2017). The population impact of obesity, sedentary lifestyle, and tobacco and alcohol consumption on the prevalence of type 2 diabetes: Analysis of a health population survey in Chile, 2010. PLoSONE 12(5): e0178092.

https://doi.org/10.1371/journal. pone.0178092

[9].   Bray, F., Ferlay, J. M. E., Soerjomataram, I., Siegel, R. L., Torre, L. A., Jemal, A. Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA: Journal for clinicians; 68 (6) 394- 424. First published: 12 September 2018

https://doi.org/10.3322/caac.21492.

[10].  Bommer, C., Heesemann, E., lova, V. S., Manne-Goehler, J., Atun, P. R., Bärnighausen, T., Vollmer, S. (2017). The global economic burden of diabetes in adults aged 20–79 years: a cost-of-illness study. The Lancet. Diabetes & Endocrinology: 5 (6) 423-430.

https://doi.org/10.1016/S2213-8587(17)30097-9.

[11].  Dabelea, D., Rewers, A., Stafford, J. M., Standiford, D. A., Lawrence, J. M., Saydah. (2014). Search for Diabetes in Youth Study Group: Trends in the prevalence of ketoacidosis at diabetes diagnosis: the SEARCH for diabetes in youth study. Pediatrics, 133(4), e938–e945. doi: 10.1542/peds.2013-2795.

[12].  Global status report on alcohol and health 2018. Geneva: World Health Organization; 2018. License: CC BY-NC-SA 3.0 IGO.

[13].  Grant, B. F., Chou, S. P., Saha, T. D., Pickering, R. P., Kerridge, B. T., Ruan, W. J., … Hasin, D. S. (2017). Prevalence of 12- Month alcohol use, high-risk drinking, and DSM-IV alcohol use disorder in the United States, 2001-2002 to 2012-2013: Results from the national epidemiologic survey on alcohol and related conditions. JAMA psychiatry, 74(9), 911–923. doi: 10.1001/jamapsychiatry.2017.2161.

[14].  Holst, C., Becker, U., Jørgensen, M. E., Grønbæk, M., Tolstrup, J. S. (2017). Alcohol drinking patterns and risk of diabetes: a cohort study of 70,551 men and women from the general Danish population. Diabetologia 60:1941–1950: DOI: 10.1007/s00125-017-4359-3.

[15].  Insel, R. A., Dunne, J. L., Atkinson, M. A., Chiang, J. L., Dabelea, D., Gottlieb., … Ziegler, A. G. (2015). Staging Pre-symptomatic Type 1 Diabetes: A Scientific Statement of JDRF, the Endocrine Society, and the American Diabetes Association. Diabetes Care 2015; 38:1964–1974 | DOI: 10.2337/dc15-1419.

[16].  Joanna Kaluza, Holly R Harris, Anders Linden, Alicia Wolk. (2019). Alcohol Consumption and Risk of Chronic Obstructive Pulmonary Disease: A Prospective Cohort Study of Men, American Journal of Epidemiology, 188 (5), 907– 916. https://doi.org/10.1093/aje/kwz020.

[17].  Kalla, A. V & Figueredo, M. (2017). Alcohol and cardiovascular disease in the geriatric population, Clinical Cardiology; 40:444–449. DOI: 10.1002/clc.22681.

[18].  Kaphalia, L. & Calhoun, W. J. alcoholic lung injury: metabolic, biochemical and immunological aspects. Toxicology letters 222(171-179): http://doi.org/10.1016/j.toxlet.2013.07.016.

[19].  Klatsky, A. L. (2015). Alcohol and cardiovascular diseases: where do we stand today? Review. Journal of internal medicine. Doi: 10.1111/joim.12390.

[20].  Liberati A, Altman DG, Tetzlaff J, Mulrow C, Gøtzsche PC, Ioannidis JPA, et al. (2009) The PRISMA Statement for Reporting Systematic Reviews and Meta-Analyses of Studies That Evaluate Health Care Interventions: Explanation and Elaboration. PLoS Med 6(7): e1000100. https://doi.org/10.1371/journal.pmed.100010020.

[21].  Li, X., Yu, F., Zhou, Y., & He, J. (2016). Association between alcohol consumption and the risk of incident type 2 diabetes: a systematic review and dose-response meta-analysis. Am J Clin Nutr 2016; 103:818–29. Printed in USA. 2016 American Society for Nutrition. Available on

https://academic.oup.com/ajcn/article-abstract/103/3/818/4637587 accessed on 31 August 2019.

[22].  Ratna, A & Mandrekar, P. (2017). Alcohol and Cancer: Mechanisms and Therapies. Biomolecules, 7, 61; Doi: 10.3390/biom7030061. Available at https://www.mdpi.com/journal/biomolecules.

[23].  Rehm, J., Gerhard, E. G. M., Gerrit, G., Omer, S. M., Hasan, S. I., Svetlana, P., Charlotte, P., Michael… Paul, A. S. (2017). The relationship between different dimensions of alcohol use and the burden of disease—an update. Addiction, 112, 968 –1001. doi: 10.1111/add.13757.

[24].  Siu, A. L., Domingo, K. B., Grossman, D. C., Davidson, K. W., EplingJr, J. W., García, F.A.R., … Pignone, M. P. (2016). Screening for chronic obstructive pulmonary disease. US Preventive services Task Force; Recommendation statement. JAMA.2016; 315(13): 1372-1377.doi: 10.1001/jama.2016.2638.


[25].  Skyler, J. S., Bakris, G. L., Bonifacio, E., Darsow, T., Eckel, R. H., Groop, L., Ratner, R. E. (2017). Differentiation of diabetes by pathophysiology, natural history, and prognosis. Diabetes, 66(2), 241–255. Doi: 10.2337/db16-0806.

[26].  Taylor, A. E., Lu, F., Carslake, D., Hu, Z., Qian, Y., Liu, S., Smith, G. D. (2015). Exploring causal associations of alcohol with cardiovascular and metabolic risk factors in a Chinese population using Mendelian randomization analysis. Scientific reports, 5, 14005. Doi: 10.1038/srep14005.

[27].  Vogelmeier, C. F., Criner, G. J., Martinez, F. J., Anzueto, A., Barnes, P. J., Bourbeau, J., … Agust, A. Global Strategy for the Diagnosis, Management, and Prevention of Chronic Obstructive Lung Disease 2017 Report GOLD Executive Summary. Am J Respir Crit Care Med 195 (5) 557–582. Mar 1, 2017; DOI: 10.1164/rccm.201701-0218PP.

[28].  Voskoboinik, A., prabhu, S., Ling, L., Kalman, J. M., Kistler, P.M. (2016). Alcohol and atrial fibrillation. A sobering review. Journal of the American college of cardiology; 68 (23); ISSN 0735-1097/$36.00. http://dx.doi.org/10.1016/j.jacc.2016.08.074

[29].  World Health Organization, Global report on diabetes. (2016). 1. Diabetes Mellitus – epidemiology. 2. Diabetes Mellitus – prevention and control. 3. Diabetes, Gestational. 4. Chronic Disease. 5. Public Health. I. World Health Organization. ISBN 978 92 4 156525 7 (NLM classification: WK 810). Available at http://www.who.int.

[30].  World Health Organization (2017). Chronic Disease and Health Promotion. STEP wise approach to surveillance (STEPS). Geneva World Health Organization. Global Health Observatory Data; Risk Factors [Internet]. 2017. Available at: http://www.who.int/gho/ncd/risk_factors/en/ [accessed 29 July 2019].

World Health Organization. (2018) “Non- communicable diseases, “fact sheet. Available at. http://www.who.int/topics/noncommunicable_diseases/en/. Accessed on 22nd July. 2019.